Fig. 2From: Effect of CYP3A4 inhibitor and induction on the pharmacokinetics and safety of FHND9041, a novel EGFR T790M inhibitor, in healthy ChineseFlowchart of Rifampicin + FHND9041 group administrationBack to article page
